GSK has licensed its shigella vaccine candidate to Bharat Biotech. The Big Pharma, which has vowed to help Bharat with trial design and fundraising, framed the deal as a way to get the vaccine to ...
GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal with Flagship Pioneering. Flagship’s Profound Therapeutics and Quotient ...
For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer (CDTO) worked for years at tech giants like Apple and Salesforce before making ...
GSK plc will pay Frontier Biotechnologies Inc. $40 million up front and up to $963 million in milestone payments to license two of Frontier’s small interfering RNA-based assets in the field of ...
GlaxoSmithKline (GSK) will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology, and inflammation (RI&I) as well as oncology, through a collaboration ...
GSK has become the latest pharma giant to direct investment away from the UK as it unveiled a new plan to spend $30bn (£22bn) on research and manufacturing facilities in the US. The London-based ...
Healthcare company GSK has introduced a new brand identity meant to suggest the merging of science, technology and talent. The logo was redesigned by Omnicom's brand consultancy Wolff Olins. The ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min GSK reached out to a big RAPT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results